Does METHYLPREDNISOLONE Cause Type v hyperlipidaemia? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Type v hyperlipidaemia have been filed in association with METHYLPREDNISOLONE (Medroloan II SUIK). This represents 0.0% of all adverse event reports for METHYLPREDNISOLONE.
10
Reports of Type v hyperlipidaemia with METHYLPREDNISOLONE
0.0%
of all METHYLPREDNISOLONE reports
0
Deaths
10
Hospitalizations
How Dangerous Is Type v hyperlipidaemia From METHYLPREDNISOLONE?
Of the 10 reports, 10 (100.0%) required hospitalization, and 2 (20.0%) were considered life-threatening.
Is Type v hyperlipidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METHYLPREDNISOLONE. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does METHYLPREDNISOLONE Cause?
Off label use (10,364)
Drug ineffective (9,959)
Product use in unapproved indication (4,115)
Condition aggravated (3,784)
Headache (3,419)
Fatigue (3,250)
Pyrexia (3,226)
Pain (3,165)
Nausea (3,105)
Pneumonia (3,006)
What Other Drugs Cause Type v hyperlipidaemia?
SACUBITRIL\VALSARTAN (25)
ASPIRIN (24)
CARVEDILOL (23)
ATORVASTATIN (22)
RAMIPRIL (22)
ALENDRONATE (21)
DAPAGLIFLOZIN (21)
ALLOPURINOL (19)
EPLERENONE (19)
EZETIMIBE (19)
Which METHYLPREDNISOLONE Alternatives Have Lower Type v hyperlipidaemia Risk?
METHYLPREDNISOLONE vs METHYLPREDNISOLONE ACEPONATE
METHYLPREDNISOLONE vs METHYLPREDNISOLONE HEMISUCCINATE
METHYLPREDNISOLONE vs METILDIGOXIN
METHYLPREDNISOLONE vs METOCLOPRAMIDE
METHYLPREDNISOLONE vs METOLAZONE